Oxford BioMedica provided capital expenditure guidance for the year 2015/2016. For the year, the company expected capital expenditure to be in the range of £20 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
305.5 GBX | -0.33% |
|
-6.89% | +38.18% |
May. 09 | Avon Protection wins UK MoD supply deal; Molten Ventures up | AN |
May. 09 | Molten Ventures wins UK MoD supply contract | AN |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+38.18% | 389M | |
+18.15% | 124B | |
+18.02% | 112B | |
+4.31% | 22.94B | |
-9.86% | 17.02B | |
-16.47% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B | |
+106.26% | 10.31B |
- Stock Market
- Equities
- OXB Stock
- News Oxford Biomedica plc
- Oxford BioMedica Provides Capital Expenditure Guidance for the Year 2015/2016